ERBB2 and breast carcinoma: During our investigation of the in vitro anti-cancer mechanisms of AZD4547, we found that AZD4547 suppresses cell proliferation and cell cycle progression in ErbB2-overexpressing breast cancer cell lines (Fig. 1).